. Author manuscript; available in PMC: 2016 Nov 15.

Published in final edited form as: Clin Trials. 2010 Jun 22;7(5):584–596. doi: 10.1177/1740774510373120

Table 2.

Response rates for two treatments and one marker in five scenarios.

	Scenario 1		Scenario 2		Scenario 3		Scenario 4		Scenario 5
	MK		MK		MK		MK		MK
TX	−	+	−	+	−	+	−	+	−	+
1	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.1	0.3
2	0.2	0.2	0.2	0.4	0.4	0.4	0.2	0.6	0.2	0.6

	Scenario 1		Scenario 2		Scenario 3		Scenario 4		Scenario 5
	MK		MK		MK		MK		MK
TX	−	+	−	+	−	+	−	+	−	+
1	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.1	0.3
2	0.2	0.2	0.2	0.4	0.4	0.4	0.2	0.6	0.2	0.6

	Scenario 1		Scenario 2		Scenario 3		Scenario 4		Scenario 5
	MK		MK		MK		MK		MK
TX	−	+	−	+	−	+	−	+	−	+
1	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.1	0.3
2	0.2	0.2	0.2	0.4	0.4	0.4	0.2	0.6	0.2	0.6

	Scenario 1		Scenario 2		Scenario 3		Scenario 4		Scenario 5
	MK		MK		MK		MK		MK
TX	−	+	−	+	−	+	−	+	−	+
1	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.1	0.3
2	0.2	0.2	0.2	0.4	0.4	0.4	0.2	0.6	0.2	0.6